Shi­madzu launches near-in­frared imag­ing sys­tem

BioSpectrum (Asia) - - SUPPLIER NEWS -

Shi­madzu Cor­po­ra­tion has en­tered the med­i­cal near-in­frared cam­era mar­ket with the re­lease of a new LIGHTVISION near-in­frared flu­o­res­cence imag­ing sys­tem. The new LIGHTVISION is de­signed to sup­port breast can­cer treat­ment through the visu­al­iza­tion of lymph ves­sels and blood ves­sels based on the de­tec­tion of near-in­frared flu­o­res­cent light emit­ted from in­do­cya­nine green (ICG).

Due to the in­creas­ing rate of breast can­cer mor­bid­ity, Shi­madzu has in­vested sig­nif­i­cant re­sources to­wards ap­ply­ing state-of-the-art sci­ence and tech­nol­ogy sup­port­ing the di­ag­no­sis and treat­ment of breast can­cer. The new LIGHTVISION sys­tem has been de­vel­oped as part of this on­go­ing ini­tia­tive.

The new LIGHTVISION sys­tem cre­ates real time con­trast im­ages of lymph ves­sels be­low tis­sue sur­faces by ad­min­is­ter­ing ICG through the lymph ves­sels, ex­pos­ing the cor­re­spond­ing tis­sue to ex­ci­ta­tion light, and then de­tect­ing and vi­su­al­iz­ing the slight emis­sion of near-in­frared light from the ICG, which is in­vis­i­ble to the naked eye. By vi­su­al­iz­ing the lymph ves­sels dur­ing surgery, the sur­geon can per­form sur­gi­cal pro­ce­dures while mon­i­tor­ing the po­si­tion of lymph ves­sels be­ing ex­cised, for example, on a mon­i­tor screen. This is es­pe­cially use­ful for iden­ti­fy­ing the po­si­tion of sen­tinel lymph nodes, which are im­por­tant for di­ag­nos­ing the metas­ta­sis sta­tus of can­cer cells dur­ing breast can­cer surgery.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.